The IDF Middle East and North Africa (MENA) Region consists of 21 countries that have experienced massive social and economic changes. A total of 33 data sources from 17 countries were used to estimate diabetes prevalence in 20–79 year-old adults in the Region. Jordan, Pakistan and Sudan had national studies conducted within the past five years. Algeria, Jordan, Oman, Pakistan, Saudi Arabia, State of Palestine, Sudan and United Arab Emirates had estimates based on oral glucose tolerance tests (OGTT). Diabetes prevalence for the remaining countries may be underestimated. The MENA Region has studies of type 1 diabetes incidence data in the 0–19 age-group covering over half the countries in the Region (12 countries).
At a glance | 2010 | 2019 | 2030 | 2045 |
---|---|---|---|---|
Diabetes estimates (20-79 y) | ||||
People with diabetes, in 1,000s | 26,646.0 | 54,777.1 | 76,016.9 | 107,641.2 |
Age-adjusted comparative prevalence of diabetes, % | 9.3 | 12.2 | 13.3 | 13.9 |
People with undiagnosed diabetes, in 1,000s | - | 24,461.2 | - | - |
Proportion of people with undiagnosed diabetes, % | - | 44.7 | - | - |
Impaired glucose tolerance (IGT) estimates (20-79 y) | ||||
People with IGT, in 1,000s | 24,404.0 | 35,494.4 | 47,338.8 | 64,485.6 |
Age-adjusted comparative prevalence of IGT, % | 8.2 | 9.2 | 9.7 | 9.9 |
Mortality attributable to diabetes (20-79 y) | ||||
Deaths attributable to diabetes | 294,035.0 | 418,865.8 | - | - |
Proportion of diabetes-related deaths in people under 60 y, % | - | 53.3 | - | - |
Type 1 diabetes estimates in children and adolescents | ||||
New cases of type 1 diabetes (0-14 y), in 1,000s | 9.1 | 14.4 | - | - |
New cases of type 1 diabetes (0-19 y), in 1,000s | - | 20.8 | - | - |
Type 1 diabetes (0-14 y), in 1,000s | 54.4 | 82.9 | - | - |
Type 1 diabetes (0-19 y), in 1,000s | - | 149.4 | - | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
Live births affected by HIP | - | 1,871,313.0 | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | 7.5 | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | 476,165.6 | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | 596,211.7 | - | - |
Diabetes-related health expenditure | ||||
Total diabetes-related health expenditure, USD million | 5,575.4 | 24,926.0 | 32,474.2 | 38,556.2 |
Total diabetes-related health expenditure, ID million | 11,255.7 | 74,849.6 | 96,964.8 | 112,652.2 |
Mean diabetes-related health expenditure per person, USD | 483.0 | 475.3 | - | - |
Mean diabetes-related health expenditure per person, ID | 596.0 | 1,469.6 | - | - |
Demographics | ||||
Total adult population (20-79 y), in 1,000s | 344,469.0 | 426,328.1 | 533,755.7 | 686,702.3 |
Population of children (0-14 y), in 1,000s | 203,810.0 | 237,085.8 | - | - |
Population of children and adolescents (0-19 y), in 1,000s | - | 301,469.2 | - | - |